# MEMORA — Production Readiness Assessment

> **Phase 40 — Deployment Readiness Evaluation**

---

## 1. Readiness Summary

| Readiness Domain | Status | Detail |
| :--- | :--- | :--- |
| **Architectural Readiness** | ✅ READY | 19 subsystems complete, tested, and certified |
| **Offline Readiness** | ✅ READY | OFFLINE_CLINICAL profile validated; cognitive execution persists without network |
| **Edge Readiness** | ✅ READY | SMARTPHONE, SMARTWATCH, SMART_GLASSES, OFFLINE_CLINICAL profiles validated |
| **Clinical Data Readiness** | ✅ READY | FHIR/HL7 adapters translate clinical records into payload-neutral IOMessages |
| **Safety Readiness** | ✅ READY | Trust, security, escalation, and protocol isolation verified |
| **Determinism Readiness** | ✅ READY | Snapshot checksums reproducible; identical inputs → identical outputs |
| **Deployment Readiness** | ⚠️ CONDITIONAL | Requires platform-specific SDK bridges (Android/iOS) for physical deployment |

---

## 2. What Is Ready

MEMORA's cognitive architecture is **complete and verified**. The following capabilities are fully implemented:

- **Perception** → Process visual, audio, and sensor inputs
- **Cognitive OS** → Working memory, attention management, decision engine
- **Trust & Safety** → Content safety validation, PII protection, degradation management
- **Behaviour Intelligence** → Routine learning, drift monitoring, predictive assistance
- **Cognitive Reasoning** → Multi-modal evidence fusion, conflict resolution
- **Executive Function** → Goal planning, task graph execution, interruption recovery
- **Experience Learning** → Execution history, pattern recognition, confidence calibration
- **Semantic Knowledge** → Entity-relationship world model, fact provenance
- **Long-Term Memory** → Memory encoding, deduplication, recall, retention, forgetting
- **Clinical Runtime** → Service lifecycle, fault isolation, recovery orchestration
- **Cognitive Sessions** → Session lifecycle, execution traces, context propagation
- **Integrity** → Cross-subsystem health validation, reference consistency
- **Configuration** → Centralized policy management, profile switching
- **Security** → Role-based access control, identity management, audit attribution
- **Unified I/O** → Technology-agnostic input/output gateways
- **Interoperability** → FHIR/HL7 clinical data translation
- **Assistance** → Context restoration, routine guidance, object finding, reassurance
- **Caregiver Intelligence** → Patient timelines, longitudinal trends, escalation policies
- **Edge Runtime** → Hardware-agnostic device profiles, resource-aware execution

---

## 3. Remaining Risks Before Patient Deployment

> [!IMPORTANT]
> RC1 represents **architectural readiness**, not approval for clinical use. The following items require dedicated engineering, regulatory, and clinical effort before real-world patient deployment.

| Risk Area | Severity | Description | Required Action |
| :--- | :--- | :--- | :--- |
| **Sensor Integration** | HIGH | Camera, microphone, and wearable sensor SDKs are abstracted but not connected to physical hardware | Implement platform-specific sensor bridges |
| **Mobile Applications** | HIGH | No Android/iOS/WearOS app exists | Build native apps consuming EdgeEngine and IOEngine APIs |
| **Clinical Validation** | HIGH | Architecture validated, but clinical efficacy with real Alzheimer's patients is unproven | Conduct IRB-approved clinical studies |
| **Security Hardening** | MEDIUM | RBAC and audit logging are implemented but not penetration-tested | Conduct professional security audit |
| **Regulatory Pathway** | MEDIUM | MEMORA may be classified as a medical device in some jurisdictions | Engage regulatory counsel |
| **Privacy & Compliance** | MEDIUM | HIPAA, GDPR, and regional privacy compliance requires legal review | Conduct compliance assessment |
| **Human Factors** | MEDIUM | UI/UX for patients, caregivers, and clinicians is not implemented | Conduct usability testing |
| **ML Model Quality** | LOW | Perception models (face detection, object detection) are placeholder-grade | Train and validate production models |

---

## 4. Future Roadmap

```
Product Development
        │
        ▼
Clinical Validation
        │
        ▼
Pilot Deployment
        │
        ▼
Field Trials
        │
        ▼
Production Release
```

### Phase Descriptions

1. **Product Development**: Build mobile apps, wearable apps, caregiver dashboards, and clinician portals consuming MEMORA's APIs.
2. **Clinical Validation**: Partner with clinical institutions for IRB-approved studies with Alzheimer's patients and their caregivers.
3. **Pilot Deployment**: Deploy MEMORA with a small cohort of patients in controlled clinical environments.
4. **Field Trials**: Expand deployment to diverse real-world environments (homes, assisted living facilities).
5. **Production Release**: Full-scale deployment with regulatory approval where applicable.

---

## 5. Assessment Authority

- **Assessed By**: MEMORA Production Readiness Review Board
- **Date**: 2026-07-30
- **Verdict**: **ARCHITECTURALLY READY FOR PRODUCT DEVELOPMENT**
